Table 1

Baseline clinical characteristics of the study subjects (n = 26)

CharacteristicIntervention (n = 15)Control (n = 11)Pa
Age
 Median (range)61 (51–71)61 (53–70)
 Mean ± SEb62.3 ± 1.962.0 ± 1.80.92
Race
 African American23
 Caucasian American1380.62
Baseline clinical stagec
 T1C104
 T2A24
 T2B330.13a
Baseline Gleason score
 ≤6115
 >6460.23
Baseline plasma PSA (ng/ml)6.89 ± 0.81b6.74 ± 0.880.89
  • a P is for comparing the distribution of T1 versus T2 in the two groups.

  • b Mean + SE.

  • c American Urologic Association (AUA) Staging System: T1C, tumor on needle biopsy of nonpalpable mass; T2A, tumor involving one lobe; T2B, tumor involving both lobes.